Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
A Multicenter, Randomized, Double Blind, Restasis®-Controlled Non-inferiority, Moisview® Eye Drops-controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
Sponsor: Huons Co., Ltd.
A PHASE3 clinical study on Dry Eye Syndrome, this trial is completed. The trial is conducted by Huons Co., Ltd. and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
May 2020 — Jun 2020 [monthly]
Unknown Status PHASE3
Status: Enrolling By Invitation → Unknown Status
-
Feb 2019 — May 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Enrolling By Invitation PHASE3
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Huons Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .